Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy

John William Sidhom, Giacomo Oliveira, Petra Ross-MacDonald, Megan Wind-Rotolo, Catherine J. Wu, Drew M. Pardoll, Alexander S. Baras

Research output: Contribution to journalArticlepeer-review

Abstract

T cell receptor (TCR) sequencing has been used to characterize the immune response to cancer. However, most analyses have been restricted to quantitative measures such as clonality that do not leverage the complementarity-determining region 3 (CDR3) sequence. We use DeepTCR, a framework of deep learning algorithms, to reveal sequence concepts that are predictive of response to immunotherapy. We demonstrate that DeepTCR can predict response and use the model to infer the antigenic specificities of the predictive signature and their unique dynamics during therapy. The predictive signature of nonresponse is associated with high frequencies of TCRs predicted to recognize tumor-specific antigens, and these tumor-specific TCRs undergo a higher degree of dynamic changes on therapy in nonresponders versus responders. These results are consistent with a biological model where the hallmark of nonresponders is an accumulation of tumor-specific T cells that undergo turnover on therapy, possibly because of the dysfunctional state of these T cells in nonresponders.

Original languageEnglish (US)
Article numbereabq5089
JournalScience Advances
Volume8
Issue number37
DOIs
StatePublished - Sep 2022

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy'. Together they form a unique fingerprint.

Cite this